Coalition of Women Living with HIV and Aids (Cowlha) says an initiative they introduced to promote adherence to ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Pa r tner s yes terday described Malawi’s human rights agenda as being on the right track ahead of the country’s Universal ...

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

Since the first case of HIV in the U.S. nearly 44 years ago, the country has made significant progress towards eradicating the disease. Now on the cusp of ending the epidemic, roadblocks from ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

Accurate monitoring of CD4+ T cell counts is vital for evaluating immune health and guiding treatment in people living with Human Immunodeficiency Virus (HIV).

HIV discovery could open door to long-sought cure Date: May 30, 2025 Source: University of Virginia Health System Summary: New HIV research shows that small changes in the virus affect how quickly ...

CD4 T-Cell Monitoring in HIV Management Key Themes: Immune Reconstitution: Average CD4 count increases of approximately 200 cells in the first year of effective therapy ...

JOHANNESBURG, May 14 (Reuters) - Testing and monitoring of HIV patients across South Africa have fallen since the United States cut aid that funded health workers and clinics, with pregnant women ...